파이프라인 기술을 통한 시장 출시 기간 단축

Getting potential products from the research phase to a licensed commercial manufacturing facility faster is pipeline acceleration.

This involves accelerating a potential new product in the research pipeline as it progresses from the early research stages, through process development, to
clinical stages, and finally, to commercial manufacturing. It is critical to bring a new therapeutic to market as quickly as possible. Product definitions are evolving
to include process steps, process parameters, important material attributes, and critical quality attributes. As more is learned about the process, this information
is actively managed to ensure a successful new drug is launched. Technology transfer speeds up the process of managing the transfer of this information
from one organization or facility to another and decreases the chance of error.

Managing and maintaining recipes and formulas is one of the most important processes in the Life Sciences industry. Being able to share research findings from product development through to new product production across the organization enables faster approval and introduction of new therapeutics and can make a big impact on profitability. Digitally closing the gap between drug discovery and production will allow you to transfer recipe parameters and validate recipes faster while minimizing the risk of misinterpreting information or entering data incorrectly. With data available across the lifecycle of a product, learnings about products, platforms, and processes can be shared to optimize the design of new processes, minimize equipment-related process problems, more quickly evaluate deviations in manufacturing based on the history of the product, and reduce the time and effort to manage what has historically been paper or simple file-based solutions.